Consequently, by integrating the pathogenesis of chronic prostatitis with the function of TRPV1 in the sensitization of internal organs, it is crucial to develop TRPV1-targeted drugs that are safe, efficient, and have minimal side effects for the management of prostatitis in the future. Here, TRPV1 is linked to urogenital neoplasm.